APA (7th ed.) Citation

Jung, H. J., Kim, Y. S., Kim, S. G., Lee, Y. N., Jeong, S. W., Jang, J. Y., . . . Kim, B. S. (2014). The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients. Clinical and molecular hepatology, 20(1), 38-46. https://doi.org/10.3350/cmh.2014.20.1.38

Chicago Style (17th ed.) Citation

Jung, Hee Jae, Young Seok Kim, Sang Gyune Kim, Yun Nah Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, and Boo Sung Kim. "The Impact of Pegylated Interferon and Ribavirin Combination Treatment on Lipid Metabolism and Insulin Resistance in Chronic Hepatitis C Patients." Clinical and Molecular Hepatology 20, no. 1 (2014): 38-46. https://doi.org/10.3350/cmh.2014.20.1.38.

MLA (9th ed.) Citation

Jung, Hee Jae, et al. "The Impact of Pegylated Interferon and Ribavirin Combination Treatment on Lipid Metabolism and Insulin Resistance in Chronic Hepatitis C Patients." Clinical and Molecular Hepatology, vol. 20, no. 1, 2014, pp. 38-46, https://doi.org/10.3350/cmh.2014.20.1.38.